{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:43:51Z","timestamp":1784735031287,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.082","type":"journal-article","created":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T09:02:10Z","timestamp":1254474130000},"page":"6974-6982","source":"Crossref","is-referenced-by-count":23,"title":["Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults"],"prefix":"10.1016","volume":"27","author":[{"given":"Richarda M.","family":"de Voer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R.M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla W.A.M.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger M.","family":"Schepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van de Kassteele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ger T.","family":"Rijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.082_bib1","series-title":"Universal vaccination against meningococcal serogroup C and pneumococcal disease","author":"Gezondheidsraad\/Health Council of the Netherlands","year":"2002"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.082_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"de Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.082_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.09.082_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","article-title":"Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults","volume":"18","author":"Richmond","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.082_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.082_bib6","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.082_bib7","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.082_bib8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom","volume":"186","author":"Borrow","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine","volume":"24","author":"Snape","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"7659","key":"10.1016\/j.vaccine.2009.09.082_bib10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.082_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/CVI.00059-06","article-title":"Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?","volume":"13","author":"Tsai","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.082_bib12","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein\u2013polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard-Rohner","year":"2008","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.082_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/CVI.00478-07","article-title":"Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides","volume":"15","author":"de Voer","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/CDLI.11.2.272-279.2004","article-title":"Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135","volume":"11","author":"Lal","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.09.082_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.082_bib17","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/515298","article-title":"Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines","volume":"177","author":"Anttila","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.082_bib18","series-title":"Mixed-effects models in S and S-PLUS","author":"Pinheiro","year":"2002"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1185\/03007999909113370","article-title":"Kinetics of antibody response to Haemophilus influenzae type b vaccines","volume":"15","author":"Madore","year":"1999","journal-title":"Curr Med Res Opin"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.09.082_bib20","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/S0264-410X(01)00050-0","article-title":"Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A\/C polysaccharide vaccine and vaccine-naive controls","volume":"19","author":"Borrow","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.082_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00365549609027150","article-title":"Circulating antibody secreting cells and humoral antibody response after parenteral immunization with a meningococcal polysaccharide vaccine","volume":"28","author":"Nieminen","year":"1996","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.082_bib22","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/CVI.00279-08","article-title":"Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era","volume":"15","author":"Trotter","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.082_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.smim.2004.02.008","article-title":"Immunological memory in humans","volume":"16","author":"Crotty","year":"2004","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.082_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4049\/jimmunol.176.1.165","article-title":"Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival","volume":"176","author":"Pihlgren","year":"2006","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.082_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1521-4141(200103)31:3<939::AID-IMMU939>3.0.CO;2-I","article-title":"Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life","volume":"31","author":"Pihlgren","year":"2001","journal-title":"Eur J Immunol"},{"issue":"5601","key":"10.1016\/j.vaccine.2009.09.082_bib26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.082_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.180.1.361","article-title":"Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice","volume":"180","author":"DiLillo","year":"2008","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.082_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.082_bib29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/517407","article-title":"Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization","volume":"177","author":"Goldblatt","year":"1998","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.082_bib30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/323648","article-title":"Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant","volume":"184","author":"Wuorimaa","year":"2001","journal-title":"J Infect Dis"},{"issue":"9320","key":"10.1016\/j.vaccine.2009.09.082_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0950268899002915","article-title":"Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine","volume":"123","author":"Borrow","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.082_bib33","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/IAI.68.5.2692-2697.2000","article-title":"Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents","volume":"68","author":"Zhang","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.09.082_bib34","unstructured":"Schouls LM, de Greeff SC. RIVM Report: The National Immunisation Programme in the Netherlands. 2008; 210021008\/2008. p 34."},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.082_bib35","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.082_bib36","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-induced epitopic suppression, a major issue for future synthetic vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib37","first-page":"223","article-title":"Carrier-induced suppression of the antibody response to a \u2018self\u2019 hapten","volume":"74","author":"Sad","year":"1991","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.082_bib38","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.082_bib39","first-page":"364","article-title":"Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine","volume":"78","author":"Panpitpat","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.082_bib40","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.09.082_bib41","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0264-410X(01)00328-0","article-title":"Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes","volume":"20","author":"Nanan","year":"2001","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.09.082_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20022020","article-title":"Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen","volume":"197","author":"Kruetzmann","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.082_bib43","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.082_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.it.2004.11.004","article-title":"Vaccination against encapsulated bacteria in humans: paradoxes","volume":"26","author":"Weller","year":"2005","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.082_bib45","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1128\/IAI.67.9.4935-4938.1999","article-title":"Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination","volume":"67","author":"Lottenbach","year":"1999","journal-title":"Infect Immun"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2009.09.082_bib46","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0264-410X(98)00475-7","article-title":"IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines","volume":"17","author":"Soininen","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.082_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/CVI.13.4.507-510.2006","article-title":"Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine","volume":"13","author":"Findlow","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.082_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.139.6.1999","article-title":"Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid)","volume":"139","author":"Makela","year":"1987","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.082_bib49","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.4049\/jimmunol.137.8.2670","article-title":"Isotype concentrations of human antibodies to group A meningococcal polysaccharide","volume":"137","author":"Rautonen","year":"1986","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.082_bib50","first-page":"127","article-title":"IgG2 subclass restriction of antibody to pneumococcal polysaccharides","volume":"63","author":"Barrett","year":"1986","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.082_bib51","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/IAI.60.11.4838-4847.1992","article-title":"Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid","volume":"60","author":"Bredius","year":"1992","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:49:58Z","timestamp":1685148598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09014297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":51,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09014297"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}